Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Author(s):

Abby Van Voorhees ◽

Linda Stein Gold ◽

Mark Lebwohl ◽

Et Al.

Keyword(s):

Plaque Psoriasis ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Abstract not available. Disclosures: Study sponsored by Celgene.

Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.13746 ◽

2016 ◽

Vol 31 (1) ◽

pp. 89-95 ◽

Cited By ~ 36

Author(s):

L. Cai ◽

J. Gu ◽

J. Zheng ◽

M. Zheng ◽

G. Wang ◽

...

Keyword(s):

Plaque Psoriasis ◽

Blind Study ◽

Chinese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study

10.1016/j.jaad.2015.02.937 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB232 ◽

Keyword(s):

Plaque Psoriasis ◽

Blind Study ◽

Chinese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study

10.1016/j.jaad.2020.01.072 ◽

2020 ◽

Vol 83 (1) ◽

pp. 96-103 ◽

Author(s):

Abby S. Van Voorhees ◽

Linda Stein Gold ◽

Mark Lebwohl ◽

Bruce Strober ◽

Charles Lynde ◽

...

Keyword(s):

Plaque Psoriasis ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

The Lancet ◽

10.1016/s0140-6736(18)31713-6 ◽

2018 ◽

Vol 392 (10148) ◽

pp. 650-661 ◽

Cited By ~ 139

Author(s):

Kenneth B Gordon ◽

Bruce Strober ◽

Mark Lebwohl ◽

Matthias Augustin ◽

Andrew Blauvelt ◽

...

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

14190 Treatment with secukinumab of severe plaque psoriasis in pediatric patients: Study design and baseline characteristics of a double-blind study

10.1016/j.jaad.2020.06.620 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB133

Author(s):

Andrzej Kaszuba ◽

Philemon Papanastasiou ◽

Deborah Keefe ◽

Manmath Patekar ◽

Lixin Zhang ◽

...

Keyword(s):

Study Design ◽

Plaque Psoriasis ◽

Pediatric Patients ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Baseline Characteristics

5.21 EVALUATION OF THE EFFICACY AND SAFETY OF SHP465 MIXED AMPHETAMINE SALTS AT A LOW DOSE IN CHILDREN WITH ADHD: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2019.08.335 ◽

2019 ◽

Vol 58 (10) ◽

pp. S252

Author(s):

Greg Mattingly ◽

Valerie Arnold ◽

Brian Yan ◽

Ming Yu ◽

Brigitte Robertson

Keyword(s):

Low Dose ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Children With Adhd

26197 Efficacy and safety of risankizumab vs methotrexate in patients with moderate-to-severe plaque psoriasis: Results from the 28-week randomized, double-blind period of an ongoing phase 3 study in Brazil

10.1016/j.jaad.2021.06.375 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB88

Author(s):

Tania F. Cestari ◽

Cacilda daSilva Souza ◽

Luna Azulay-Abulafia ◽

Ricardo Romiti ◽

André V.E. Carvalho ◽

...

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Ongoing Phase

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0005 ◽

2020 ◽

Vol 30 (9) ◽

pp. 549-557

Author(s):

Greg Mattingly ◽

Valerie Arnold ◽

Brian Yan ◽

Ming Yu ◽

Brigitte Robertson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Low Dose ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Hyperactivity Disorder

Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-blind, placebo-controlled study through week 12

10.1016/j.jaad.2015.02.939 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB233 ◽

Keyword(s):

Plaque Psoriasis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

A Phase 3, Randomized, Double-Blind Study To Assess the Efficacy and Safety of Fospropofol Disodium Injection for Moderate Sedation in Patients Undergoing Flexible Bronchoscopy

CHEST Journal ◽

10.1378/chest.08-0623 ◽

2009 ◽

Vol 135 (1) ◽

pp. 41-47 ◽

Cited By ~ 62

Author(s):

Gerard A. Silvestri ◽

Brad D. Vincent ◽

Momen M. Wahidi ◽

Emory Robinette ◽

James R. Hansbrough ◽

...

Keyword(s):

Flexible Bronchoscopy ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Moderate Sedation